Delisting Determination, The Nasdaq Stock Market, LLC, September 6, 2024.
Biolase, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Biolase, Inc., effective
at the opening of the trading session on September 16, 2024.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rule 5550(a)(2).
The Company was notified of the Staff determination on April 15, 2024.
On April 22, 2024, the Company exercised its right to appeal
the Staff determination to the Listing Qualifications Hearings Panel
(Panel) pursuant to Listing Rule 5815.
On May 14, 2024, the Company received an additional delist
determination pursuant to Listing Rule 5550(b)(1).
On June 17, 2024, upon review of the information provided by the
Company, the Panel determined to deny the Company request to remain
listed in the Exchange and determined to delist the Company.
The Company securities were suspended on June 20, 2024.
The Company did not appeal the delist decision to the Nasdaq Listing
and Hearing Review Council (Council) and the Council did not call
the matter for review. The Staff determination to delist the Company
became final on August 1, 2024.